The results for the 2017 CIHR-PHSI for Cancer Control research have been formally announced, and ARCC is proud to have significant involvement in the work to come. Four of the six announced projects are led by ARCC members, including projects headed by both ARCC co-directors. This represents a significant investment by (more…)
re-posted from http://www.partnershipagainstcancer.ca/new-vice-president-cancer-control/ The Canadian Partnership Against Cancer (the Partnership) has announced the appointment of Dr. Craig Earle as Vice-President, Cancer Control effective November 1, 2017. “The Partnership is privileged to have Dr. Earle bring his breadth of experience across both the Canadian and American cancer systems along with his passion (more…)
In a recent paper published in the Journal of Clinical Oncology and supported by ARCC, researchers examined whether the ASCO Value Framework and the ESMO Magnitude of Clinical Benefit Scale measure similar constructs of clinical benefit. They also looked at how both relate to quality-adjusted life-years, and funding recommendations in (more…)
We are pleased to share with you the final report on the “Making Fair & Sustainable Decisions about Funding for Cancer Drugs” collaboration. This collaboration was funded by the Canadian Partnership Against Cancer, supporting ARCC and the McMaster Health Forum. We invite you to read and download a copy today! (more…)
Click here to view this opportunity on CIHR’s websiteCIHR and other funding agencies have invested in the establishment of cohorts and databases. These cohorts and databases house high quality health systems and patient data sets and/or biospecimens. As such, there exists a wealth of information that has the potential to (more…)
Effective health care integrates palliative care into the patients’ treatment plan as early as possible, but Palliative and End-of-Life Care: A Cancer System Performance Report suggests this may not always be happening in Canada. Palliative care is not limited to end-of-life care; it is effective for pain and symptom management (more…)
Post-Doctoral Fellow, Reference #60724 Temporary Full Time (2 year term), Vancouver, BC The candidate will work with a team of world-class Scientists at the BC Cancer Agency (BCCA) for the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is an innovative pan-Canadian research centre whose mission is to (more…)
Additional details about how you can apply to this program can be found online at https://biocanrx.com/research/research-program/research-funding/application-process-and-instructions *TARGETED FUNDING CALL: BioCanRx is pleased to announce that the next call for applications is now open in the Clinical, Social & Economic Impact (CSEI) program. At this time, BioCanRx is placing highest priority on the intake (more…)
Help improve patient and public engagement in economic evaluations!March 31, 2026 - 11:21 am
**NEW** CIHR Institute of Cancer Research and ARCC Research Impact AwardsJanuary 14, 2026 - 7:54 am
CCS Research Training Awards 2024December 27, 2023 - 2:37 pm
Patient perspectives of Value Frameworks used to Guide Oncology Treatment DecisionsMay 1, 2021 - 12:27 pmHelp improve patient and public engagement in economic evaluations!March 31, 2026 - 11:21 am
Help shape the future of nature therapy for cancer care in Canada!March 30, 2026 - 10:51 am
Common Sense Oncology Survey StudyMarch 10, 2026 - 9:47 am
Connect With Us!